Apremilast*

600+42.9 mg/5 ml, 100 ml Powder for Oral Suspension (ES)

200+28.5 mg/5 ml, 70 ml and 100 ml Powder for Oral Suspension

400+57 mg/5 ml, 35 ml, 70 ml,100 ml and 140 ml Powder for Oral Suspension

250+125, 500+250, 1000+500 mg (IM/IV) Injectable (vial)

250+125, 500+250, 1000+500 mg (IM) Injectable (vial)

1mg Tablets

10, 20, 40, 80 mg Film Coated Tablet

100 mg SC Injectable (Powder for Injection)

0.05 % Ophthalmic Eye Drops (single-dose)

60 mg Capsule

35+75+60 mg Nasal Spray

1000 mg/20 ml (IV/IA) Injectable (vial) (solution for injection)

Deva EU Markets Product List

Our product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.